Moderna To Seek Covid Vaccine's Emergency Use If Data Shows High Efficacy

If Moderna Inc's COVID-19 vaccine proves to be at least 70% effective, the company plans to seek emergency authorization for its use in high-risk groups, the company's chief executive told Reuters.